title: Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
authors: C
authors: C
authors: Hermans
authors: J
authors: J
authors: Astermark
authors: P
authors: P
authors: De Moerloose
mesh_terms: D003029:Coagulants / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use*; D003661:Decision Support Techniques; D005169:Factor VIII / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use*; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D003029:Coagulants; D007518:Isoantibodies; D005169:Factor VIII